2 Stocks That Are Just Getting Started: Pattern Energy Group Inc. (NASDAQ:PEGI), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP)

The shares of Pattern Energy Group Inc. (NASDAQ:PEGI) has been pegged with a rating of Underweight by Wells Fargo in its latest research note that was published on January 09, 2020. The Utilities company has also assigned a $26.75 price target. Wells Fargo wasn’t the only research firm that published a report of Pattern Energy Group Inc., with other equities research analysts also giving their opinion on the stock. The stock had earned Neutral rating from Goldman Markets when it published its report on October 17, 2019. That day the Goldman set price target on the stock to $25. The stock was given Market Perform rating by Wells Fargo in its report released on August 14, 2019, the day when the price target on the stock was placed at 26. Macquarie was of a view that PEGI is Underperform in its latest report on February 04, 2019. BMO Capital Markets thinks that PEGI is worth Market Perform rating.

Amongst the analysts that rated the stock, 4 have recommended investors to sell it, 4 believe it has the potential for further growth, thus rating it as Hold while 0 advised investors to purchase the stock. The price of the stock the last time has raised by 41.32% from its 52-Week high price while it is -4.84% than its 52-Week low price. A look at the stock’s other technical shows that its 14-day RSI now stands at 65.37.

The shares of the company added by 0.44% during the trading session on Wednesday, reaching a low of $26.97 while ending the day at $27.12. During the trading session, a total of 2.97 million shares were traded which represents a -172.68% decline from the average session volume which is 1.09 million shares. PEGI had ended its last session trading at $27.00. Pattern Energy Group Inc. debt-to-equity ratio currently stands at 3.25, while its quick ratio hovers at 0.30 PEGI 52-week low price stands at $19.19 while its 52-week high price is $28.50.

The company in its last quarterly report recorded -$0.53 earnings per share which is below the predicted by most analysts. The Pattern Energy Group Inc. generated 106.0 million in revenue during the last quarter. In the second quarter last year, the firm recorded -$0.07 earnings per share. Compared to the same quarter last year, the firm’s revenue was up by 71.7%. Pattern Energy Group Inc. has the potential to record -0.65 EPS for the current fiscal year, according to equities analysts.

Investment analysts at Raymond James published a research note on August 23, 2019 where it informed investors and clients that ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) is now rated as Outperform. Lake Street also rated ZIOP as Initiated on April 04, 2019, with its price target of $7 suggesting that ZIOP could surge by 49.21% from its current share price. Even though the stock has been trading at $3.16/share, analysts expect it to surge by 1.27% to reach $6.30/share. It started the day trading at $3.26 and traded between $3.15 and $3.20 throughout the trading session.

A look at its technical shows that ZIOP’s 50-day SMA is 4.55 while its 200-day SMA stands at 4.79. The stock has a high of $7.25 for the year while the low is $2.41. The stock, however, witnessed a rise in its short on 01/31/20. Compared to previous close which recorded 54.73 M shorted shares, the short percentage went lower by -0.86%, as 54.26M PEGI shares were shorted. At the moment, only 31.07% of ZIOPHARM Oncology Inc. shares were sold short. The company’s P/E ratio currently sits at 4.75, while the P/B ratio is 5.16. The company’s average trading volume currently stands at 2.01M shares, which means that the short-interest ratio is just 27.22 days. Over the past seven days, the company moved, with its shift of -5.88%. Looking further, the stock has dropped -23.81% over the past 90 days while it lost -38.22% over the last six months.

The change in the stock’s fortunes has led to several institutional investors altering their holdings of the stock. The MSD Partners LP bought more ZIOP shares, increasing its portfolio by 37.91% during the last quarter. This move now sees The MSD Partners LP purchasing 4,165,258 shares in the last quarter, thus it now holds 15,151,516 shares of ZIOP, with a total valuation of $59,696,973. Miller Value Partners LLC meanwhile bought more ZIOP shares in the recently filed quarter, changing its stake to $51,153,595 worth of shares.

Similarly, The Vanguard Group, Inc. decreased its ZIOPHARM Oncology Inc. shares by 0.92% during the recently filed quarter. After selling 10,837,059 shares in the last quarter, the firm now controls -100,455 shares of ZIOPHARM Oncology Inc. which are valued at $42,698,012. In the same vein, BlackRock Fund Advisors decreased its ZIOPHARM Oncology Inc. shares by during the most recent reported quarter. The firm bought 533,629 shares during the quarter which decreased its stakes to 10,324,257 shares and is now valued at $40,677,573. Following these latest developments, around 1.70% of ZIOPHARM Oncology Inc. stocks are owned by institutional investors and hedge funds.